BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10963135)

  • 1. Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations--a link between genetics and epigenetics.
    Gebhardt F; Bürger H; Brandt B
    Histol Histopathol; 2000 Jul; 15(3):929-36. PubMed ID: 10963135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of EGFR gene transcription by a polymorphic repetitive sequence--a link between genetics and epigenetics.
    Gebhardt F; Bürger H; Brandt B
    Int J Biol Markers; 2000; 15(1):105-10. PubMed ID: 10763151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
    Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
    Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression.
    Buerger H; Gebhardt F; Schmidt H; Beckmann A; Hutmacher K; Simon R; Lelle R; Boecker W; Brandt B
    Cancer Res; 2000 Feb; 60(4):854-7. PubMed ID: 10706093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.
    Gebhardt F; Zänker KS; Brandt B
    J Biol Chem; 1999 May; 274(19):13176-80. PubMed ID: 10224073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.
    Amador ML; Oppenheimer D; Perea S; Maitra A; Cusatis G; Iacobuzio-Donahue C; Baker SD; Ashfaq R; Takimoto C; Forastiere A; Hidalgo M
    Cancer Res; 2004 Dec; 64(24):9139-43. PubMed ID: 15604284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development.
    Tidow N; Boecker A; Schmidt H; Agelopoulos K; Boecker W; Buerger H; Brandt B
    Cancer Res; 2003 Mar; 63(6):1172-8. PubMed ID: 12649171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
    Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
    PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.
    Dubey S; Stephenson P; Levy DE; Miller JA; Keller SM; Schiller JH; Johnson DH; Kolesar JM;
    J Thorac Oncol; 2006 Jun; 1(5):406-12. PubMed ID: 17409891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinib.
    Winther Larsen A; Nissen PH; Meldgaard P; Weber B; Sorensen BS
    Lung Cancer; 2014 Sep; 85(3):435-41. PubMed ID: 25017413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.
    Buerger H; Packeisen J; Boecker A; Tidow N; Kersting C; Bielawski K; Isola J; Yatabe Y; Nakachi K; Boecker W; Brandt B
    J Pathol; 2004 May; 203(1):545-50. PubMed ID: 15095477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
    Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
    Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
    Tiseo M; Capelletti M; De Palma G; Franciosi V; Cavazzoni A; Mozzoni P; Alfieri RR; Goldoni M; Galetti M; Bortesi B; Bozzetti C; Loprevite M; Boni L; Camisa R; Rindi G; Petronini PG; Ardizzoni A
    J Thorac Oncol; 2008 Oct; 3(10):1104-11. PubMed ID: 18827605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas.
    Kersting C; Agelopoulos K; Schmidt H; Korsching E; August C; Gosheger G; Dirksen U; Juergens H; Winkelmann W; Brandt B; Bielack S; Buerger H; Gebert C
    Genes Chromosomes Cancer; 2008 Aug; 47(8):657-64. PubMed ID: 18464244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
    Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.
    Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
    Ann Surg Oncol; 2007 Jul; 14(7):2150-8. PubMed ID: 17453292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone-dependent breast cancer cells.
    Wilson MA; Chrysogelos SA
    J Cell Biochem; 2002; 85(3):601-14. PubMed ID: 11968000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma.
    Suzuki M; Kageyama S; Shinmura K; Okudela K; Bunai T; Nagura K; Igarashi H; Kiyose S; Mori H; Tao H; Goto M; Takamochi K; Mochizuki T; Suzuki K; Ohashi R; Ogawa H; Yamada T; Niwa H; Tsuneyoshi T; Sugimura H
    J Surg Oncol; 2008 Nov; 98(6):457-61. PubMed ID: 18683191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene.
    Brandt B; Hermann S; Straif K; Tidow N; Buerger H; Chang-Claude J
    Cancer Res; 2004 Jan; 64(1):7-12. PubMed ID: 14729599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB.
    Nishi H; Neta G; Nishi KH; Akers LM; Rikiyama T; Proctor KN; Murphy BA; Johnson AC
    Int J Mol Med; 2003 Jan; 11(1):49-55. PubMed ID: 12469217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.